BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

950 related articles for article (PubMed ID: 15192785)

  • 1. The epidemiology of cholangiocarcinoma.
    Shaib Y; El-Serag HB
    Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for cholangiocarcinoma.
    Ben-Menachem T
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):615-7. PubMed ID: 17625428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
    Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM
    Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
    Jepsen P; Vilstrup H; Tarone RE; Friis S; Sørensen HT
    J Natl Cancer Inst; 2007 Jun; 99(11):895-7. PubMed ID: 17551150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
    Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
    Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangiocarcinoma: descriptive epidemiology and risk factors.
    de Martel C; Plummer M; Franceschi S
    Gastroenterol Clin Biol; 2010 Mar; 34(3):173-80. PubMed ID: 20202771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention.
    Parkin DM; Ohshima H; Srivatanakul P; Vatanasapt V
    Cancer Epidemiol Biomarkers Prev; 1993; 2(6):537-44. PubMed ID: 8268770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study.
    Lee TY; Lee SS; Jung SW; Jeon SH; Yun SC; Oh HC; Kwon S; Lee SK; Seo DW; Kim MH; Suh DJ
    Am J Gastroenterol; 2008 Jul; 103(7):1716-20. PubMed ID: 18557716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
    Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case-control study of risk factors in cholangiocarcinoma].
    Tao LY; He XD; Cai L; Liu W; Ji WJ; Zhao L; Zhang SM
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas.
    Qu Z; Cui N; Qin M; Wu X
    Asia Pac J Clin Oncol; 2012 Mar; 8(1):83-7. PubMed ID: 22369448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholangiocarcinoma--bile ducts cancer].
    Dubaniewicz A; Dubaniewicz A
    Wiad Lek; 2003; 56(1-2):57-60. PubMed ID: 12901270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing incidence of cholangiocarcinoma in Crete 1992-2000.
    Mouzas IA; Dimoulios P; Vlachonikolis IG; Skordilis P; Zoras O; Kouroumalis E
    Anticancer Res; 2002; 22(6B):3637-41. PubMed ID: 12552969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.
    Bertuccio P; Malvezzi M; Carioli G; Hashim D; Boffetta P; El-Serag HB; La Vecchia C; Negri E
    J Hepatol; 2019 Jul; 71(1):104-114. PubMed ID: 30910538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors of intrahepatic cholangiocarcinoma: a case-control study].
    Zhou HB; Xu QR; Wang H; Zhou DX; Wang H; Wang Q; Zhou SS; Tu QQ; Sun ZQ; Ai L; Wu MC; Hu HP
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):935-9. PubMed ID: 20038337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology of primary and secondary liver cancers].
    Jepsen P; Kissmeyer-Nielsen P
    Ugeskr Laeger; 2008 Apr; 170(16):1323-5. PubMed ID: 18433588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis.
    Jing W; Jin G; Zhou X; Zhou Y; Zhang Y; Shao C; Liu R; Hu X
    Eur J Cancer Prev; 2012 Jan; 21(1):24-31. PubMed ID: 21857525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
    Bergquist A; Broomé U
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.